{"Ticker": "CRL", "Company": "Charles River Laboratories", "Sector": "Health Care", "Updated": "2021-12-30 12:04:11", "Rating": [{"Date": "2021-08-05", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$385"}, {"Date": "2020-12-16", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$270 to $250"}, {"Date": "2020-09-10", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$254"}, {"Date": "2020-07-01", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$192"}, {"Date": "2020-05-13", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$177 to $200"}, {"Date": "2020-04-21", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$139"}, {"Date": "2020-03-27", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$152"}, {"Date": "2020-03-02", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$190"}, {"Date": "2020-02-18", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": ""}, {"Date": "2020-01-10", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$143 to $179"}, {"Date": "2020-01-08", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$180"}, {"Date": "2020-01-07", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$185"}, {"Date": "2019-10-18", "Rating": "Downgrade", "Organization": "BofA/Merrill", "Rating_Change": "Buy to Neutral", "Target_Change": "$150"}, {"Date": "2019-06-10", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Outperform", "Target_Change": "$155"}, {"Date": "2019-04-30", "Rating": "Resumed", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$160"}, {"Date": "2018-12-14", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2018-10-09", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": ""}, {"Date": "2018-08-23", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": ""}, {"Date": "2018-07-17", "Rating": "Upgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Outperform", "Target_Change": ""}, {"Date": "2018-06-15", "Rating": "Upgrade", "Organization": "KeyBanc Capital Mkts", "Rating_Change": "Sector Weight to Overweight", "Target_Change": ""}]}